Hepatocellular carcinoma: Have we finally found the ultimate staging system for HCC?

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 6, 2014, Pages 334-336

  Chapiro, Julius ^a   Geschwind, Jean François ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL PRACTICE; COHORT ANALYSIS; DECISION MAKING; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE SCORE; HEALTH CARE SYSTEM; HEALTH STATUS; HONG KONG; HONG KONG LIVER CANCER STAGING SYSTEM; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TRANSPLANTATION; LOCOREGIONAL THERAPY; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; TUMOR INVASION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84901975139     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.67     Document Type: Review

References (8)

1. Forner, A., Llovet, J. M. &Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245-1255 (2012).
2. European Association for the Study of the Liver &European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56, 908-943 (2012).
3. Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359, 378-390 (2008).
4. Burrel, M. et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design. J. Hepatol. 56, 1330-1335 (2012).
5. Llovet, J. M., Schwartz, M., Fuster, J. &Bruix, J. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there. Semin. Liver Dis. 26, 248-253 (2006). (Pubitemid 44141932)
6. Llovet, J. M., Bru, C. &Bruix, J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 19, 329-338 (1999).
7. Yau, T. et al. Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology, http://dx.doi.org/10.1053/j.gastro.2014.02.032 (2014).
8. Lencioni, R. et al. GIDEON (Global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib): second interim analysis. Int. J. Clin. Pract. http://dx.doi.org/10.1111/ijcp.12352 (2013).